Conditionally immortalized mouse embryonic fibroblasts retain proliferative activity without compromising multipotent differentiation potential

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Huang, Enyi ^a,b   Bi, Yang ^b,c   Jiang, Wei ^b   Luo, Xiaoji ^b,d   Yang, Ke ^b,e   Gao, Jian Li ^b,f   Gao, Yanhong ^b,g   Luo, Qing ^b,c   Shi, Qiong ^b,d   Kim, Stephanie H ^b   Liu, Xing ^b,c   Li, Mi ^b,c   Hu, Ning ^b,d   Liu, Hong ^b,d   Cui, Jing ^b,d   Zhang, Wenwen ^b,d   Li, Ruidong ^b,d   Chen, Xiang ^b,h   Shen, Jikun ^b   Kong, Yuhan ^b,d   Zhang, Jiye ^b,d   Wang, Jinhua ^b,d   Luo, Jinyong ^b,d   He, Bai Cheng ^b,d   Wang, Huicong ^a   Reid, Russell R ^b   Luu, Hue H ^b   Haydon, Rex C ^b   Yang, Li ^a   He, Tong Chuan ^b,c,d   more..

^a CHONGQING UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

^e THIRD MILITARY MEDICAL UNIVERSITY   (China)

^f ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^g XINHUA HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^h FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CRE RECOMBINASE; VIRUS LARGE T ANTIGEN; BONE MORPHOGENETIC PROTEIN 9; GREEN FLUORESCENT PROTEIN; INTEGRASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; VIRUS T ANTIGEN;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CELL LINEAGE; CELL PROLIFERATION; CHONDROGENESIS; CONTROLLED STUDY; DNA FLANKING REGION; EMBRYO; EMBRYONIC FIBROBLAST; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LOXP SITE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; MULTIPOTENT STEM CELL; NONHUMAN; PROTEIN EXPRESSION; SAFETY; STEM CELL EXPANSION; TRANSLATIONAL RESEARCH; ADENOVIRUS; ANIMAL; BONE MARROW CELL; CELL CULTURE; CELL LINE; CULTURE TECHNIQUE; CYTOLOGY; GENETICS; METABOLISM; NUDE MOUSE; STEM CELL; TUMOR CELL LINE;

MUS MUSCULUS;

ADENOVIRIDAE; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLASTS; GREEN FLUORESCENT PROTEINS; GROWTH DIFFERENTIATION FACTOR 2; HUMANS; INTEGRASES; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; PPAR GAMMA; STEM CELLS;

EID: 84863146866     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032428     Document Type: Article

References (71)

1. Prockop DJ, (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276: 71-74.
2. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
3. Caplan AI, Bruder SP, (2001) Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends in Mol Med 7: 259-264.
4. Tuan RS, Boland G, Tuli R, (2003) Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther 5: 32-45.
5. Rastegar F, Shenaq D, Huang J, Zhang W, Zhang BQ, et al. (2010) Mesenchymal stem cells: Molecular characteristics and clinical applications. World Journal of Stem Cells 2: 67-80.
6. Shenaq DS, Rastegar F, Petkovic D, Zhang BQ, He BC, et al. (2010) Mesenchymal Progenitor Cells and Their Orthopedic Applications: Forging a Path towards Clinical Trials. Stem Cells International 2010: 519028.
7. Hermann A, Gastl R, Liebau S, Popa MO, Fiedler J, et al. (2004) Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J Cell Sci 117: 4411-4422.
8. Keilhoff G, Goihl A, Langnase K, Fansa H, Wolf G, (2006) Transdifferentiation of mesenchymal stem cells into Schwann cell-like myelinating cells. Eur J Cell Biol 85: 11-24.
9. Wislet-Gendebien S, Wautier F, Leprince P, Rogister B, (2005) Astrocytic and neuronal fate of mesenchymal stem cells expressing nestin. Brain Res Bull 68: 95-102.
10. Makino S, Fukuda K, Miyoshi S, Konishi F, Kodama H, et al. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103: 697-705.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317.
12. Noel D, Djouad F, Jorgense C, (2002) Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs 3: 1000-1004.
13. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, et al. (2008) Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell 2: 141-150.
14. Chan JL, Tang KC, Patel AP, Bonilla LM, Pierobon N, et al. (2006) Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107: 4817-4824.
15. Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, et al. (2006) Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372.
16. Djouad F, Charbonnier LM, Bouffi C, Louis-Plence P, Bony C, et al. (2007) Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 25: 2025-2032.
17. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, et al. (2001) Multilineage cells from human adipose tissue: implications for cell- based therapies. Tissue Eng 7: 211-228.
18. Sinanan AC, Hunt NP, Lewis MP, (2004) Human adult craniofacial muscle-derived cells: neural-cell adhesion-molecule (NCAM; CD56)-expressing cells appear to contain multipotential stem cells. Biotechnol Appl Biochem 40: 25-34.
19. Ringe J, Leinhase I, Stich S, Loch A, Neumann K, et al. (2008) Human mastoid periosteum-derived stem cells: promising candidates for skeletal tissue engineering. J Tissue Eng Regen Med 2: 136-146.
20. Liu Z, Martin LJ, (2004) Pluripotent fates and tissue regenerative potential of adult olfactory bulb neural stem and progenitor cells. J Neurotrauma 21: 1479-1499.
21. In 't Anker PS, Scherjon SA, Kleijburg-van der Keur C, de Groot-Swings GM, Claas FH, et al. (2004) Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22: 1338-1345.
22. Davis AA, Temple S, (1994) A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature 372: 263-266.
23. da Silva Meirelles L, Chagastelles PC, Nardi NB, (2006) Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119: 2204-2213.
24. Coles BL, Angenieux B, Inoue T, Del Rio-Tsonis K, Spence JR, et al. (2004) Facile isolation and the characterization of human retinal stem cells. Proc Natl Acad Sci U S A 101: 15772-15777.
25. Bjerknes M, Cheng H, (2006) Intestinal epithelial stem cells and progenitors. Methods Enzymol 419: 337-383.
26. Amoh Y, Li L, Campillo R, Kawahara K, Katsuoka K, et al. (2005) Implanted hair follicle stem cells form Schwann cells that support repair of severed peripheral nerves. Proc Natl Acad Sci U S A 102: 17734-17738.
27. Wagner W, Wein F, Seckinger A, Frankhauser M, Wirkner U, et al. (2005) Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 33: 1402-1416.
28. Westerman KA, Leboulch P, (1996) Reversible immortalization of mammalian cells mediated by retroviral transfer and site-specific recombination. Proc Natl Acad Sci U S A 93: 8971-8976.
29. Cheng H, Jiang W, Phillips FM, Haydon RC, Peng Y, et al. (2003) Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg Am 85-A: 1544-1552.
30. Kang Q, Sun MH, Cheng H, Peng Y, Montag AG, et al. (2004) Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther 11: 1312-1320.
31. Luu HH, Song WX, Luo X, Manning D, Luo J, et al. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J Orthop Res 25: 665-677.
32. Kang Q, Song WX, Luo Q, Tang N, Luo J, et al. (2009) A comprehensive analysis of the dual roles of BMPs in regulating adipogenic and osteogenic differentiation of mesenchymal progenitor cells. Stem Cells Dev 18: 545-559.
33. Luther G, Wagner ER, Zhu G, Kang Q, Luo Q, et al. (2011) BMP-9 Induced Osteogenic Differentiation of Mesenchymal Stem Cells: Molecular Mechanism and Therapeutic Potentia. Curr Gene Ther 11: 229-240.
34. Luo X, Chen J, Song WX, Tang N, Luo J, et al. (2008) Osteogenic BMPs promote tumor growth of human osteosarcomas that harbor differentiation defects. Lab Invest 88: 1264-1277.
35. Haydon RC, Zhou L, Feng T, Breyer B, Cheng H, et al. (2002) Nuclear receptor agonists as potential differentiation therapy agents for human osteosarcoma. Clin Cancer Res 8: 1288-1294.
36. Peng Y, Kang Q, Cheng H, Li X, Sun MH, et al. (2003) Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling. J Cell Biochem 90: 1149-1165.
37. Tang N, Song WX, Luo J, Luo X, Chen J, et al. (2009) BMP9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signaling. J Cell Mol Med 13: 2448-2464.
38. Sharff KA, Song WX, Luo X, Tang N, Luo J, et al. (2009) Hey1 Basic Helix-Loop-Helix Protein Plays an Important Role in Mediating BMP9-induced Osteogenic Differentiation of Mesenchymal Progenitor Cells. J Biol Chem 284: 649-659.
39. Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q, et al. (2010) Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PloS One 5: e11917.
40. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, et al. (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
41. Luo J, Deng ZL, Luo X, Tang N, Song WX, et al. (2007) A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc 2: 1236-1247.
42. He BC, Chen L, Zuo GW, Zhang W, Bi Y, et al. (2010) Synergistic Antitumor Effect of the Activated PPAR{gamma} and Retinoid Receptors on Human Osteosarcoma. Clin Cancer Res 16: 2235-2245.
43. He TC, Chan TA, Vogelstein B, Kinzler KW, (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99: 335-345.
44. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, et al. (1998) Identification of c-MYC as a target of the APC pathway. Science 281: 1509-1512.
45. Peng Y, Kang Q, Luo Q, Jiang W, Si W, et al. (2004) Inhibitor of DNA binding/differentiation helix-loop-helix proteins mediate bone morphogenetic protein-induced osteoblast differentiation of mesenchymal stem cells. J Biol Chem 279: 32941-32949.
46. Luo Q, Kang Q, Si W, Jiang W, Park JK, et al. (2004) Connective Tissue Growth Factor (CTGF) Is Regulated by Wnt and Bone Morphogenetic Proteins Signaling in Osteoblast Differentiation of Mesenchymal Stem Cells. J Biol Chem 279: 55958-55968.
47. Si W, Kang Q, Luu HH, Park JK, Luo Q, et al. (2006) CCN1/Cyr61 Is Regulated by the Canonical Wnt Signal and Plays an Important Role in Wnt3A-Induced Osteoblast Differentiation of Mesenchymal Stem Cells. Mol Cell Biol 26: 2955-2964.
48. Bi Y, Huang J, He Y, Zhu GH, Su Y, et al. (2009) Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. J Cell Biochem 108: 295-303.
49. Zhu GH, Huang J, Bi Y, Su Y, Tang Y, et al. (2009) Activation of RXR and RAR signaling promotes myogenic differentiation of myoblastic C2C12 cells. Differentiation 78: 195-204.
50. Huang J, Bi Y, Zhu GH, He Y, Su Y, et al. (2009) Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells. Liver Int 29: 1569-1581.
51. Rastegar F, Gao JL, Shenaq D, Luo Q, Shi Q, et al. (2010) Lysophosphatidic acid acyltransferase beta (LPAATbeta) promotes the tumor growth of human osteosarcoma. PloS One 5: e14182.
52. Su Y, Wagner ER, Luo Q, Huang J, Chen L, et al. (2011) Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma. Oncogene 30: 3907-3917.
53. He BC, Gao JL, Zhang BQ, Luo Q, Shi Q, et al. (2011) Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Mol Pharmacol 79: 211-219.
54. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
55. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
56. Okita K, Ichisaka T, Yamanaka S, (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
57. Shi Y, Desponts C, Do JT, Hahm HS, Scholer HR, et al. (2008) Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3: 568-574.
58. Gee CJ, Harris H, (1979) Tumorigenicity of cells transformed by Simian virus 40 and of hybrids between such cells and normal diploid cells. J Cell Sci 36: 223-240.
59. Howell N, (1982) Suppression of transformation and tumorigenicity in interspecies hybrids of human SV40-transformed and mouse 3T3 cell lines. Cytogenet Cell Genet 34: 215-229.
60. Kahn P, Topp WC, Shin S, (1983) Tumorigenicity of SV40-transformed human and monkey cells in immunodeficient mice. Virology 126: 348-360.
61. Nitta M, Katabuchi H, Ohtake H, Tashiro H, Yamaizumi M, et al. (2001) Characterization and tumorigenicity of human ovarian surface epithelial cells immortalized by SV40 large T antigen. Gynecol Oncol 81: 10-17.
62. Abbondanzo SJ, Gadi I, Stewart CL, (1993) Derivation of embryonic stem cell lines. Methods Enzymol 225: 803-823.
63. Aaronson SA, Todaro GJ, (1968) Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol 72: 141-148.
64. Borowiec JA, Dean FB, Bullock PA, Hurwitz J, (1990) Binding and unwinding-how T antigen engages the SV40 origin of DNA replication. Cell 60: 181-184.
65. Prives C, (1990) The replication functions of SV40 T antigen are regulated by phosphorylation. Cell 61: 735-738.
66. Zhu JY, Abate M, Rice PW, Cole CN, (1991) The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J Virol 65: 6872-6880.
67. vom Brocke J, Schmeiser HH, Reinbold M, Hollstein M, (2006) MEF immortalization to investigate the ins and outs of mutagenesis. Carcinogenesis 27: 2141-2147.
68. Counter CM, Hahn WC, Wei W, Caddle SD, Beijersbergen RL, et al. (1998) Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. Proc Natl Acad Sci U S A 95: 14723-14728.
69. Kang MK, Park NH, (2007) Extension of cell life span using exogenous telomerase. Methods Mol Biol 371: 151-165.
70. Geserick C, Tejera A, Gonzalez-Suarez E, Klatt P, Blasco MA, (2006) Expression of mTert in primary murine cells links the growth-promoting effects of telomerase to transforming growth factor-beta signaling. Oncogene 25: 4310-4319.
71. Lee MK, Hande MP, Sabapathy K, (2005) Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci 118: 819-829.